Skip to menu Skip to content Skip to footer

DEVELOPMENT OF A NOVEL BIOMATERIAL FOR BONE TISSUE ENGINEERING (2003)

Abstract

Tissue engineering of bone is emerging as a viable therapy for treating large defects in load-bearing bone. We wish to develop methods for combining novel heparan sulphate molecules (known to deliver growth factors to cell surfaces and thereby cause changes in bone cell phenotype) with load-bearing, macro-porous, biodegradable mineral/polymer biomaterials. Through the study of release profiles, protein adsorption and cell responses to these derivatised biomaterials, a novel approach to bone replacement materials can be developed. ''

Experts

Professor Matt Trau

Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Medicine
ARC Laureate Fellow and Senior Group Leader
Australian Institute for Bioengineering and Nanotechnology
Professor and ARC Laureate Fellow
School of Chemistry and Molecular Biosciences
Faculty of Science
Matt Trau
Matt Trau

Professor Lisbeth Grondahl

Professor
School of Chemistry and Molecular Biosciences
Faculty of Science
Lisbeth Grondahl
Lisbeth Grondahl

Professor Simon Cool

Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Medicine
Professor and Director of UQ Advanced Cell Therapy Manufacturing Initiative
School of Chemical Engineering
Faculty of Engineering, Architecture and Information Technology
Simon Cool
Simon Cool